43rd ISICEM

P164

Evangelos Giamarellos?Bourboulis

Innate immune characteristics of COVID pneumonia: impact of the period of the pandemia

P165

Tero Ala-Kokko

Postmortem analyses of myocardial microrna expression in sepsis

P167

Mélanie Dechamps

Septic shock is associated with a substantial change in the platelet lipidome

P168

Silvia Cermelli

Use of NEWS2 and SeptiCyte® rapid in acutely ill patients suspected of sepsis

P169

Jun Jin

Association of serum iron levels with mortality in sepsis patients: a retrospective study using the MIMIC-IV database

P170

Lisa Mellhammar

A proteomic definition of sepsis

P171

Fang Yuan

Prevalence, early predictors, and outcomes of sepsis in neurocritical illnesses: a prospective cohort study

P173

Axel Goch Gustafsson

Can heparin binding protein be of additive value to lactate for the identification of sepsis alert patients in need of vasopressor treatment?

P174

Gabriele Melegari

Pancreatic stone protein plasma level of COVID-19 patients with sepsis

P176

Evangelos Giamarellos?Bourboulis

Circulating H3.1-nucleosomes as an index of sepsis-induced immunoparalysis: preliminary data from the ImmunoSep trial

P177

Lisa Mellhammar

Molecular sepsis subphenotypes

P178

Eleni Karakike

Sepsis clinical phenotypes complement but do not overlap with immunological phenotypes: secondary analysis of a randomized controlled trial